Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users

PHASE4CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

December 31, 2006

Study Completion Date

June 30, 2007

Conditions
Substance-Related DisordersHepatitis
Interventions
DRUG

Pegylated Interferon

Weekly injections of pegIntereferon

Trial Locations (1)

98104

Harborview Medical Center, 325 Ninth Ave 1EC32, Seattle

All Listed Sponsors
collaborator

University of Washington

OTHER

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00194480 - Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users | Biotech Hunter | Biotech Hunter